Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2019 08:02 ET | Source: Stereotaxis, Inc.

Stereotaxis and Osypka Enter Strategic Collaboration to Advance Robotic Catheter Technology

Development of next generation robotically-navigated magnetic ablation catheter fully owned by StereotaxisCatheter designed to enhance patient care, improve therapy delivery, simplify catheter...
May 09, 2019 08:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2019 First Quarter Financial & Operational Results

ST. LOUIS, May 09, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
April 29, 2019 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Showcase Innovation and Technology at Heart Rhythm 2019 and Report First Quarter 2019 Financial Results on May 8-9, 2019

Innovation Update Presentation on the Evening of May 8 at Heart Rhythm SocietyInnovation Update Press Releases and First Quarter Financial Release Issued Prior to the Market Open on May 9First Quarter...
March 15, 2019 16:30 ET | Source: Stereotaxis, Inc.

Stereotaxis to Highlight Latest Techniques for Performing Robotic Ablations at European Heart Rhythm Association Annual Congress March 17-19

ST. LOUIS, March 15, 2019 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it...
March 15, 2019 12:59 ET | Source: Stereotaxis, Inc.

Stereotaxis and Acutus Medical Combine Robotic Precision and High-Resolution Imaging to Treat Arrhythmias in First Integrated Procedures

First patients successfully treated with robust integration of technologiesIntegrated technologies now commercially available ST. LOUIS and CARLSBAD, Calif., March 15, 2019 (GLOBE NEWSWIRE) --...
March 12, 2019 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2018 Full Year Financial Results

Record high annual recurring revenue of $27.8 million; 3% annual growthPositive annual net income for the first time in Company history despite significantly increased R&D investmentsInnovation...
March 04, 2019 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019

ST. LOUIS, March 04, 2019 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it...
February 19, 2019 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Participate in BTIG Healthcare Investor Conference

ST. LOUIS, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that...
January 24, 2019 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Announces Partnership with Kansas City Heart Rhythm Institute to Bring New Treatment to Arrhythmia Patients

ST. LOUIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias announced today a partnership...
November 26, 2018 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Present at the 11th Annual LD Micro Main Event Investor Conference

ST. LOUIS, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that...